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Background: With the accelerating development of bioscience, the problem of research cost has become
important. We previously devised and developed a novel concept microarray with manageable volumes (MMV)
using a soft gel. It demonstrated the great potential of the MMV technology with the examples of 1024-parallel-cell
culture and PCR experiments. However, its full potential failed to be expressed, owing to the nature of the material
used for the MMV chip.
Results: In the present study, by developing plastic-based MMVs and associated technologies, we introduced novel
technologies such as C2D2P (in which the cells in each well are converted from DNA to protein in 1024-parallel),
NGS-non-dependent microbiome analysis, and other powerful applications.
Conclusions: The reborn MMV-microarray technology has proven to be highly efficient and cost-effective (with
approximately 100-fold cost reduction) and enables us to realize hitherto unattainable technologies.
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For drug discovery, high-throughput screening is ulti-
mately required. This is similar to those in various other
scientific fields in which optimal conditions and com-
binations must be verified. The rising cost of reagents
has motivated the development of microminiaturization
technologies such as microarrays and microfluidics. For
example, microplates have evolved from 96–384 wells to
up to 3456 wells, lowering assay cost owing to the re-
duction of the amount of reagents and samples [1,2].
However, even the 3456-well plate requires μL volumes
for handling, due to adsorption and evaporation losses.
In recent years, many digital PCR systems such as the
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unless otherwise stated.toward the miniaturization of assay vessels by permitting
gene expression analysis at the nL scale [3,4]. Moreover,
picoliter-droplet digital PCR system is capable of ana-
lyzing millions of picoliter-sized droplets for molecular
genotyping [5]. However, these systems are highly spe-
cialized for specific purposes, requiring specific liquid
handlers and digital PCR instruments [6]. In addition,
multistep reactions are, in principle, difficult to perform
on these platforms, confining their applicability to mo-
lecular genotyping and a few other assays.
Microfluidics and bead-based technologies have been
developed and are currently still expanding their possi-
bilities [7-10]. These technologies have the potential to
deal with minute amounts of sample and, particularly in
microfluidics, support multistep reactions and detection.
However, there are some difficulties in microfluidics in
supporting the high density of parallel operations owing
to the difficulty in supplying a uniform force to drive
liquids [11], avoiding losses from surface adsorption, andl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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bead handling requires highly specialized machines that
cannot be readily used for general purposes [14], al-
though they are useful for specific purposes such as ran-
dom multiple sequencing [15]. In summary, current
innovative methods have their own merits but require
further development to reach their goal such as high
cost performance.
Here, we describe a reborn MMV-microarray technol-
ogy, i.e., microarray with manageable volumes, operated
without pipettes. Pipette-free operation offers several
benefits, for instance, rapid operation, handling of nano-
liter volumes, avoiding adsorption and evaporation los-
ses during operations, and dispensing with elaborate
equipment. This technology was originally developed
using polyacrylamide gel [16,17] and had the main draw-
backs of fragility and difficulty of accurate handling, al-
though it has already enabled us to culture bacteria and
perform PCR reactions [17]. The method reported here
could overcome these defects, thereby strengthening the
MMV technology.
Microarray technology has permitted a high density of
parallelism and the development of various methods
[18,19]. However, this technology has the constraint that
it essentially comprises surface reactions and is difficult to
use for successive and independent multistep reactions.Figure 1 MMV chip construction and basic operation. (a) Dimensions o
0.2 cm and is fabricated with 1024 wells of 0.6-mm diameter and 2-mm de
of solution. Well-to-well transfer of solution is performed using a silicone/u
donor to the acceptor MMV. (c) Schematic representation of initial input o
confine the solution to the top surface of the MMV.The MMV technology solves this problem and has a po-
tential to support novel applications. In the present study,
this potential to enhance the basic MMV technology is
described.Results
Sub-μL liquid handling technique
In this study, we developed novel necessary tools and
principal technologies for pipette-free sub-μL volume
handling in MMV, which were not available for MMV
made from gel (Figure 1a). The main principle of MMV is
“aperture-to-aperture transfer.” Parallel transfer of thou-
sands of solutions was performed by centrifugation of a
face-to-face stack of two MMVs with each well tightly
contacting the other via an adhesive spacer (Figure 1b).
Initial charging with sample was performed as shown in
Figure 1c. Similarly, various operation techniques have
been developed, including those described in our previous
report [17], and are collectively presented in Table 1
(for detail, see Additional file 1: Table S1, Additional file 2:
Figure S1, Additional file 3: Figure S2, Additional file 4:
Figure S3, Additional file 5: Figure S4, Additional file 6:
Figure S5, Additional file 7: Figure S6, Additional file 8:
Figure S7, Additional file 9: Figure S8, Additional file 10:
Figure S9).f an MMV chip. The MMV chip has a dimension of 2.5 cm × 2.5 cm ×
pth, giving a volume of 0.5 μL of solution. (b) Usual transfer (Z-mode)
rethane spacer that enables a leak-proof flow of solution from the
f solution into wells (I-mode). A urethane/silicone frame is used to
Table 1 Basic transfer operations needed for MMV
Operation (Pipette-dependence modea) Purpose Details
PF 1 Input (I-mode) Liquid charging into MMV wells Figure 1c
2 Output (O-mode) a. Transfer Complete ejection of liquid in wells Figure 1b and Additional file 6: Figure S5
b. Washing
3 Square transfer (S-mode) Fractional volume transfer Additional file 2: Figure S1
4 Z-direction transfer (Z-mode) Normal transfer of liquid into wells Figure 1b and Additional file 5: Figure S4
5 X-direction transfer (X-mode) Division of liquid in all wells Additional file 7: Figure S6
6 Magnetic beads transfer (M-mode) a. Beads recovery Beads recovery Additional file 8: Figure S7
b. Division of liquid Division of liquid in all wells Additional file 9: Figure S8
7 Filtering (F-mode) Filter-selective transfer Figure 2a
PD 8 Pipette-dependent transfer (P-mode) a. Manual Manual transfer of liquid or beads Additional file 10: Figure S9
b. Robotic Robotic transfer of liquid or beads Additional file 3: Figure S2
aPipette-free (PF) or pipette-dependent (PD).
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specific wells was achieved by exploiting specifically pat-
terned filters (Figure 2a). In the MMV square transfer
(S-mode) method, different volumes of solutions were
transferred using the MMV-matching thin filter device
(Additional file 2: Figure S1). Although in general,
“well-to-well transfer” had been adopted in the MMV
technology and could accomplish most necessary
operations, we also developed an automated liquid
handling (P-mode) system to achieve versatility and ma-
nageability, expanding the ability of the MMV system
(Additional file 3: Figure S2).
Generation of replicas of cell-to-cell (C2C) and
DNA-to-DNA (D2D)
To demonstrate the efficient multistep parallel transfer of
solutions, MMVs containing DNA and cells in desired pat-
terns were fabricated and used to test replica generation
(Additional file 4: Figure S3a and b). The MMV chip con-
taining E. coli cells in a pattern (cherry blossom) was
subjected to successive five rounds of forward [from the
donor MMV (original) to the acceptor MMV (replica)]
and backward transfer [transfer back of solution from the
acceptor MMV (replica) to the donor MMV (original)]
with replacement of each acceptor MMV chip. The vacant
acceptor chips were then filled with Davis media and incu-
bated at 37°C for 21 h. As shown in Figure 3a, every rep-
lica chip reproduces the original cherry blossom pattern
beginning with the vacant state, demonstrating the ef-
fectiveness of the replica generation technique. As the
original itself can be readily amplified, we can produce
replicas perpetually. Close observation of these patterns in-
dicated that 1% or fewer of the wells stochastically failed
to amplify cells within this incubation time. In an auxiliary
experiment, a very small amount of aliquot (approximately
0.1% of the total solution) was shown to be left in each
vacant well (Additional file 4: Figure S3c and d) and servedas a seed for the next bacterial culture. Therefore, although
the current system is subject to stochastic errors at a level
of 0.1%, it can be used with careful monitoring of each
well's state (presence of an aliquot) under a microscope.
Otherwise, it can be safely used by making multiple copies
(3–4) of each sample. This situation can be greatly
improved with the use of a much finer, though more
expensive casting mold to generate a next-generation
MMVchip.
Similar repetitive forward and backward transfer ex-
periments were performed with DNA solution, and va-
cant MMV chips were filled with a reaction buffer and
then subjected to PCR. As shown in Figure 3b, the 10th
replica was completely replicated, showing that a DNA
replica array was also successfully generated. In an inde-
pendent experiment, cross-contamination between wells
was shown to be eliminated by the introduction of a
packing spacer (of the same shape as the MMV chip
and with a thickness of 0.8 mm) (Figure 1b and see
Additional file 5: Figure S4 for actual unit transfer). To
our knowledge, this is the first success in perpetual
DNA microarray replica formation (DNA microarray
replication effective only once for all was reported in a
previous study) [20].
Generation of 1024 conditions (multiple-conditioner)
To exploit the array nature of MMV, we generated 1024
different conditions by applying the “2N method” [17]
(Additional file 11: Figure S10 and Additional file 12). To
investigate the crystallization conditions of lysozyme, ten
types of template MMVs were used to generate 210
(=1024) different conditions (Figure 2a). The conditions
ranged from pH 2.9 to 9.6 and from 0 to 1.5 M NaCl
(Additional file 13: Figure S11a). Typical crystal images
that were obtained are shown in Figure 2b and Additional
file 13: Figure S11, and they comprised type I (0.1–0.2-mm
large tetragonal), type II (tetragonal larger than 0.2 mm),
Figure 2 Generation of 1024 different conditions. (a) A set of filters used to generate multiple conditions in an MMV chip. In each of these
filters, if the N-bit is 1 (“go”) for the (i + 1)-th least significant bit in the binary number, then the corresponding position of filter Fi is a hole
(allowing the liquid to pass through). On selective addition of 10 species of materials to an acceptor MMV using these filters, 1024 different conditions
(corresponding to 1024 different binary numbers) were generated (for detail, see Additional file 11: Figure S10). (b) Lysozyme crystallization in MMV.
The 1024 different conditions were generated for determining the optimum crystallization conditions. A combination of pH differences (2.9–9.6) and
NaCl concentration differences (0–1.5 M) was examined (see Methods). In the inset, magnified images are shown for some MMV wells. The scale bar
is 100 μm.
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(needle-like) crystals. This result showed the most optimal
conditions (pH 8.6 and 0.6 M NaCl) for generating the lar-
gest crystal (0.65 mm; Additional file 13: Figure S11a and
b) of lysozyme as well as the conditions under which other
types of crystals can be obtained. This crystal size of lyso-
zyme seems to be relatively large, although one of 1.6 mm
has recently been reported [21]. The sample amount re-
quired for a single condition was in the mg range for that
experiment, but only 10 μg (100-fold smaller) for ours.
Microbiome analysis without dependence on NGS
Identifying all the members of microbiome found in an
ecosystem is important for genuine understanding. Ac-
cordingly, next-generation sequencing (NGS), which is apowerful, but expensive technique has been used for
microbiome analysis [22-24]. The amount of information
obtained using this method is often too great for the
mere identification of organisms.
Another method could identify the species of organisms
with cost-effective performance, i.e., genome profiling
(GP) [25]. In this study, we investigated the possibility of
MMV-dependent GP analysis of microbiomes. Its entire
procedure is shown in Figure 4a. Several crucial features
are included in this method; they are as follows: i) limiting
the dilution of organisms constituting a microbiome entity
into a single cell, ii) performing single-cell PCR by
random PCR, iii) performing GP analysis using micro-
temperature gradient gel electrophoresis (μTGGE), and
iv) obtaining the sequence information of each cloned
Figure 3 Generation of the MMV replica. (a) Cell replica. The liquid in the original MMV containing E. coli cells (harboring the GFP plasmid) in
which the wells collectively resemble a cherry blossom pattern was transferred and returned, leaving a minute droplet in each replica MMV
(upper rows #1 ~ 5). All these MMVs were added with culture media and incubated at 37°C for 21 h to regenerate cells (lower row). (b) DNA
replica. The replica image is that of the 10th replication (PCR amplified), whereas the original MMV is shown just after the 10 rounds of replica
generation operation. Both are stained with SYBR green I.
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multiple MMV microvessels to reduce the quantity of re-
agents required. In this study, dispersion of some of the
flocculated bacteria was found to be a problem. However,
this problem was substantially addressed, as shown in
Methods (enzymatic treatment and sonication, although
approximately 1% of the number of flocs remained after
this treatment). The second feature addresses the difficulty
of single-cell PCR [26] and the lack of a common PCR pri-
mer for all microbes. Fortunately, random PCR is in effect,
which is a universal PCR that can be applied to any organ-
ism using the same primer [27]. Thus, we could easily
overcome this problem. Much experience with single-cell
PCR has been accumulated both worldwide [28-30] and in
our laboratory [26].
Thus, it is no longer difficult to perform single-cell PCR,
if precautions are taken to avoid adsorption loss and DNA
contamination. The third feature (GP analysis using
μTGGE) is supported by prior experience [25,26,31-34].
The final feature can be realized by another benefit of the
GP method, i.e., the existence of easily assignable (from its
band pattern in the electrophoresis) and PCR-recoverable
DNA, namely, a commonly conserved genetic fragment
(ccgf) [31] that can be amplified from DNA extracted
from a gel band using the same primer adopted for
random PCR.
With solutions to each technical challenge, oral mi-
crobes were used as a test case and subjected to the en-
tire NGS-non-dependent microbiome analysis (NNMA)
shown in Figure 4a.
Figure 4b clearly demonstrates that some MMV wells
generated distinct genome profiles (original data in
Additional file 14: Figure S12) by the GP method, sug-
gesting a successful microbial cell distribution in differentMMV wells and extraction and amplification of DNA in
each well. The DNAs recovered from the μTGGE gel as
ccgfs were further analyzed by conventional cloning and
sequencing analysis, and the resulting DNA sequences
were subjected to BLAST analysis (Figure 4c). In this ana-
lysis, Leuconostoc citreum, Haemophilus parainfluenzae,
Rothia dentocariosa, R. mucilaginosa, Aspergillus nidu-
lans, Cronobacter sakazakii, and Psychrobacter sp. were
tentatively identified based on sequence similarity with or-
ganisms in the NCBI database (see Additional file 15:
Table S2). Because all these microbes can be assigned as
stable or transient oral inhabitants, this finding strongly
supported the inference that NNMA analysis was per-
formed without obstacles.
The genome profiles and species identification dots
(spiddos) that were obtained in this analysis (Figure 4b)
were subjected to clustering analysis (Figure 4d), in
which clones were assigned to possible species based on
their own ccgf DNA sequence (Figure 4c and Additional
file 15: Table S2).
In this experiment, not all but only some clones (47 of
them) appearing in an MMV plate were processed to test
the feasibility of the entire NNMA process because this
number was sufficient to confirm experimental success.
The same microbiome analysis was performed three
times, with all tests performed using possible clones
and their genome profiles (spiddos) (Additional file 16:
Table S3), thereby supporting the effectiveness of the
NNMA method.
Discussion
In this paper, we have established the basic technology
for the MMV handling and three typical applications of
the MMV method: replica generation, generation of
Figure 4 (See legend on next page.)
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(See figure on previous page.)
Figure 4 Schematic representation of NGS-non-dependent microbiome analysis (NNMA). (a) A sample containing a complex mixture of
microbes was serially diluted to a concentration corresponding to one or fewer cell/well as expectation value (in Poisson distribution). DNA
extraction and random PCR were performed on the same MMV chip. The PCR product was scaled up using PCR in a 96-well plate and analyzed
using μTGGE. In the genome profile obtained, feature points were assigned and processed using computer-aided normalization, generating
species identification dots (spiddos). Based on spiddos, a genome distance, dG [defined as 1 − PaSS (pattern similarity score)], was obtained for each
pair of microbes (Additional file 12), and a clustering tree was then generated using dG. (b) Genome profiles of four samples with feature points
assigned. Red dots represent feature points (pre-spiddos) and yellow dots, internal reference points. Arrow shows possible commonly conserved
genetic fragment (ccgf). (c) Partial sequences of ccgfs. Point mutations are shown with red letters. Completely matching regions are shown with
lines. (d) Clustering tree for nine samples. Here, tentative microbial species are assigned from the sequence obtained for ccgf. The tree was
constructed using Phylip 3.69 and MEGA 5.1 software.
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solution (containing DNA or cells) can be repeatedly
used for replica generation. According to the require-
ment, replicas containing defective wells can be repaired
by the operation of a nanoliter-dispensing robot (see
Additional file 3: Figures S2 and Additional file 17:
Figure S13). In effect, this technology enables us to
produce DNA, cell, and even protein arrays easily and
endlessly. The quality of the replica thus generated is suffi-
ciently reliable if MMV is loaded with samples in multi-
ples of 10 (because the expected defect rate is <1 in 10,
implying that more than 9 of 10 wells are intact). In
addition, the use of a higher-quality MMV chip mold
(a matter of cost) is empirically known to improve the de-
fect rate greatly. Moreover, monitoring the content of each
individual well (parameters such as volume, temperature,
and conductivity) is within our scope and achieved by
semiconductor technology.
Another important point is that the success of cell-to-
cell (C2C) and DNA-to-DNA (D2D) replications implies
that by combining cell-to-DNA (C2D) (Figure 4) and
DNA-to-peptide/protein (D2P) [17] (Additional file 18:
Figure S14), we can achieve C2D2P, thus beginning with
cells and ending with a protein (peptide) microarray, an
outcome that was never attainable before.
We generated 1024 conditions for lysozyme crys-
tallization. This application of MMV is unexpectedly
powerful and widely applicable because it circumvents
lengthy and time-consuming preparation processes and
spares reagents. The crystallization study described here
was performed only to demonstrate the utility and cap-
acity of the 1024-well MMV technology (because such
research has already been performed [17,21,35-37]), and
to show that a high volume of information can be readily
obtained with high performance. In this experiment, we
obtained crystals that were larger than 200 μm in a much
smaller volume (0.5 μL) than that used in previous studies
[21,35,36], thus sparing samples and reagents by about
100-fold in comparison with conventional approaches, al-
though a more competitive (∼150-fold) reduction tech-
nique has been reported that employs 81 microwells and
a specially fabricated apparatus [37]. Additionally, we
evaluated the reproducibility of the optimal crystallizationconditions at the 50 μL scale, resulting in crystals that
were around 0.65 mm long (Additional file 13: Figure
S11b). If necessary, a more statistically reliable and realis-
tic approach can be applied to examine each condition in
quadruplex or octuplex. Even in an octuplex test, more
than 100 conditions can be readily examined in a single
MMV chip test, with only 4 μL (0.5 μL × 8) consumed per
condition.
The conditions that can be examined are not only
those for crystallization of proteins, but also those for
the combinatorial effect of biological factors (hormones,
cytokines, and others) on induction of cell differentiation
such as iPS (induced pluripotent stem cell) induction. In
the field of medicinal chemistry, more effective drug
combinations (synergy effect) may be easily found owing
to the readiness in generating multiple conditions with
ease and low cost. Because chemical and biological ex-
periments originally require surveys over a wide experi-
mental range and multiple assays, the problems of cost,
labor, and time-consuming processes, which have in-
hibited desirable experiments, can be revolutionarily
solved by the MMV approach.
Furthermore, the NNMA system is a potential method
for identifying the component species of microbiomes.
To date, we have had no effective method to analyze a
huge microbiome population mainly because we lacked
an appropriate container to accommodate a large num-
ber of microbes separately and efficiently, i.e., accommo-
dating a single organism per well and enabling a series
of DNA extraction processes, PCR amplification, and
DNA sequence analysis in multiples with an affordable
cost in reasonable time. This situation was, for the first
time, overcome by the advent of NGS, a technology
worthy of the intensive attention of microbiologists.
However, NGS is not always effective; it is very expen-
sive, and the raw data generated is generally too difficult
to process except by bioinformatics specialists. A signifi-
cant amount of data accordingly remains unprocessed.
In contrast, the NNMA system enables microbiologists
to design and complete their study on their own.
The following potential advantage of NNMA over NGS
further supports this approach: NNMA can deal with an
organism as a whole, whereas NGS yields a mixture of
Sharma et al. BMC Biotechnology 2014, 14:78 Page 8 of 13
http://www.biomedcentral.com/1472-6750/14/78genome fragments for analysis. Thus, the latter renders it
impossible to further investigate the organism, as it is the-
oretically difficult to detect extreme minorities such as
one or fewer in 1000, whereas NNMA offers the possi-
bility of detecting, in principle, a minority of 1 in 10000 if
twenty or more 1024-well MMV plates are used in the
dilution with the expectation of 0.5 cell/well. This is
the essential difference between the NGS and NNMA
approaches.
A few points remain to be improved for the NNMA
analysis, including an increase in the output of μTGGE
with sample scale reduction. The realization of scale
reduction will eliminate the scale-up step required in the
current NNMA process (Figure 4a). Another goal is to
develop a means of complete deflocculation (although this
is a classical and difficult problem [38,39]), because in
the present experiment, flocs were still present (Additional
file 19: Figure S15), consistent with our observation that
DNAs from a single well of MMV are sometimes assigned
to different species (Additional file 15: Table S2). This ob-
servation is noteworthy because the current NNMA sys-
tem, although it remains to be improved in techniques
outside the MMV technology proper, has already suc-
ceeded in extracting DNAs from microbes, from either
single or flocculated cell(s), and amplifying, analyzing, and
assigning them to species using MMV-based technology—
a feat never achieved by conventional approaches such as
microplate-based technologies.
In this study, all necessary basic skills and tools for the
MMV operations have been described. Moreover, highly
usable application methods have been proposed.
In addition, there are other potentially powerful appli-
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peptides against cancer cells.
b+++, successfully achieved; ++, whole process developed with tentative confirmatpossible drug molecules termed as panning on micro-
array MMV (POMM) (Additional file 18: Figure S14)
and All-In-One and All-At-Once (AI/AO) (Table 2). The
former (POMM) is a multistep reaction experiment,
comprising PCR, replica formation, enzymatic reactions
(transcription/translation), and fluorescence detection
supported by multiple operations of well-to-well trans-
fers. The latter is simple and wide ranging, such that the
diversities of its usage are open to researchers, par-
ticularly when pre-charged MMVs with various samples
such as buffers, DNAs, enzymes, bead-bound antibodies,
and cells are available from commercial sources in the
future. If necessary, all one has to do is to purchase a
pre-charged MMV with diverse conditions and overlay it
on an experimenter's MMV (containing one's own sam-
ples). Similarly, an analyst can identify the optimal me-
dium for culturing a particular cell (iPS or cancer cell)
using an MMV of a combinatorial set of factors (gene-
rated by the 2N method).
The MMV technology has the merits of simple operation,
rapidity, economy, reduced error rate, and flexibility to both
classical microscope-based technologies (phase-contrast,
fluorescence, and others) and emerging semi-conductor-
based technologies (Additional file 20: Figure S16).Conclusions
The plastic-based MMV chip enabled us to develop an
easy-to-handle and quantitative system in handling sub-
μL volumes. It also facilitated the development of a set of
necessary unit technologies for MMV operation such as
input, output, division, filtering of solutions, and others.
This development has led to genuinely novel methodsLevel achievedb Comment
+++ Applicable to iPS primary
induction factor screening
+++ Proteins replica can be
perpetually generated by two
steps of D2D and D2P, i.e.,
D2D2P.
+++ Serves as single cell isolation and
analysis tool
++ Screening tool with samples
addressed
+ Applicable to monoclonal
antibody screening
ion; +, system developed with successful preliminary experiment.
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(C2D2P) and NNMA.
In addition, MMV can reduce experimental time and
cost drastically (Additional file 21: Table S4).
Methods
The most basic nature of the MMV technology can be
represented by the facts that the liquid in an MMV well
does not fall by the gravity and is less volatile due to the
narrow aperture area, easily thermo-conductive due to
the small volume, and readily mixed by convection.
MMV chip
Polycarbonate (PC) MMV chips were developed in a
joint project, involving most of the authors, which was
sponsored by JST, and were finally obtained from Enplas
Corporation. The MMV chip has an overall dimension
of 2.5 × 2.5 cm2, with diameter, depth, and volume of
0.6 mm, 2 mm, and 0.5 μL, respectively (Figure 1a). PC
MMV is classified into the two following types according
to the chip's bottom: i) PC molded and ii) transparent
sheet pasted. For microscopic observation, the second
type is used. Silicone rubber or PDMS was also used for
fabricating flexible well-size MMV chips [17].
Charging and discharging of liquid into MMV (I-mode)
Initial charging of sample into wells can be achieved by
centrifugation force as shown in Figure 1c; with excess
solution covering the top surface of MMV, it was centri-
fuged at 1400 g for 1 min to fill all the wells with solu-
tion and evacuate the remaining solution from MMV
wells (Figure 1c).
As I-mode is a kind of dump transfer, a specific one-by-
one transfer is carried out by P-mode as written in Table 1.
In order to prevent evaporation, MMV was sealed with
silicone tape (Rescue Tape), and to remove liquid from
MMV wells, centrifugation was applied to the MMV
placed upside down (at 1400 g for 2 min) (Additional
file 6: Figure S5). One MMV chip can be repeatedly reused
by several rounds of washing with ultrapure water and/or
70% ethanol by centrifugation and ultrasonic vibration.
Liquid can be transferred from one well of an MMV to
another well of an opposing MMV by centrifugation. A
silicone-PET-adhesive spacer (0.2-mm thick with 0.6-mm
wide holes) (Finetech) was fixed on the donor MMV
and then the acceptor MMV was firmly laid against it
(Figure 1b). The liquid moves from the donor to the
acceptor MMV through the thin channel in the spacer
without evaporation or adsorption losses.
Further, to add a droplet solution, S-mode operation
(Additional file 2: Figure S1) was applied. This type of
spacer was repeatedly used, and, if necessary, the thick-
ness and/or hole patterns of the spacer were changed.
Layers from bottom to top, namely MMV (used assupport), a bottom-side-adhesive film attached to the
MMV, and a spacer of desired thickness and hole pat-
tern, were constructed and matched to charge the wells
with the solution in the square method.
Selective addition to specific wells (F-mode)
For this purpose, different types of filter spacers were
produced (Finetech) and used (examples in Figure 2a).
These spacers are adhesive and contain different surface
patterns of holes and without holes, enabling selective
transfer of samples to the acceptor MMV. As an alterna-
tive solution, template MMVs having a specific pattern
of open and closed wells can be used for the same pur-
pose. Such templates could be formed using PDMS and
a laser patterning machine [17].
MMV coating
To prevent adsorption of biomolecules on MMV surfaces,
MMVs were mainly surface coated with a solution of 0.1%
(w/v) bovine serum albumin (BSA), obtained from Sigma-
Aldrich, by centrifugation (at 1400 g for 1 min). These
were used for cell culturing, PCR, and other operations.
The aperture of this MMV was sealed with silicone tape
and incubated overnight at 4°C. After incubation, the solu-
tion was removed by centrifugation (O-mode), and the
MMV was dried at room temperature for 1 h.
Replica formation
A typical example of replica formation is shown in
Additional file 4: Figure S3, where a cherry blossom pat-
tern was formed on MMV using two colors (Elements 1
and 2). Element 1 was charged in E1-MMV using a #1
filter with a thickness of 0.3 mm and a hole diameter of
0.5 mm for expression of the cherry blossom pattern.
E2-MMV contained Element 2 in the complementary pat-
tern of Element 1. Here, Element 1 was a DNA (Aβ 42-
binding peptide gene)-containing PCR mixture, whereas
Element 2 contained no DNA. The PCR mixture com-
prised 1× FB I buffer (Takara), 250 μM dNTP mixture,
0.04 μM CA primer (5′-CAACACACCACCCACCC
AAC-3′), and 0.025 U/μL SpeedSTAR HS DNA poly-
merase (Takara). Both E1- and E2-MMVs were subjected
to PCR and then combined to generate the original MMV.
This original MMV was used for the replica formation by
a stamping method wherein a spacer with a thickness of
0.8 mm and hole diameter of 0.6 mm (Finetech) was in-
terposed between the original (donor) and the acceptor
MMVs. The centrifugal transfer (1300 g for 1 min) from
the donor to the acceptor MMV was reversed just after
the first transfer, resulting in the generation of an MMV in
which a very small aliquot remained. This aliquot can
serve as a seed for PCR amplification (DNA), thus repro-
ducing a replica.
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described above. For this demonstration, GFP-plasmid-
harboring Escherichia coli cells were used and cultured
in LB broth [0.5% (w/v) yeast extract, 1% (w/v) tryptone,
and 1% (w/v) NaCl with 0.1 μg/μL ampicillin and 1 mM
IPTG]. Here, Element 1 corresponds to GFP-harboring
E. coli and Element 2 to LB medium without cells.
MMV setup in a conventional thermocycler
In a conventional thermocycler (Bio-Rad C1000 Touch),
for better heat conduction, a copper plate was inserted
between the PCR block and the MMV chip. In addition,
MMV was sealed with silicone tape, occluded with
aluminum foil, and installed in the thermocycler. Sili-
cone rubber was used to closely pack the MMV to pro-
tect against pressure.
Imaging of MMV reaction products
The staining of PCR products with SYBR Green I
(Lonza) was performed using a shallow well MMV
(0.1 μL/well) according to the manufacturer’s instruc-
tions. Before the transfer (1300 g for 1 min) of the dye
from the shallow MMV to the PCR-product-containing
MMV, the contents of the latter were reduced in ad-
vance by dry air-driven evaporation (lid was left open on
a clean bench for few minutes) to make space for the
solution to be transferred. Further, MMV with stained
DNA was monitored using a fluoroimager (Molecular
Imager FX, Bio-Rad). MMV with E. coli cells was visua-
lized by FITC staining and monitored using the same
fluoroimager.
Lysozyme crystallization
We applied the 2N method to test 1024 different con-
ditions for lysozyme crystallization (Additional file 11:
Figure S10 and Additional file 12). Lyophilized powder of
lysozyme (Sigma-Aldrich) was dissolved in 5 mM MES
buffer (pH 6.6) [final concentration of 28% (w/v), final
volume of 1 mL]. This solution was carefully vortexed to
eliminate any visible flocs of lysozyme and filtered through
a membrane filter (0.2-μm pore size), and the supernatant
was collected for use in the crystallization experiment.
Stepwise different pH values were generated with filter
spacers of F0, F1, F2, F3, and F4 (Figure 2a; S-mode
operation) charged with approximately 40 nL of 1 M
sodium citrate buffer (pH 2.9), 1 M sodium acetate buffer
(pH 3.9), 1 M MES-NaOH (pH 6.6), 1 M Tris–HCl
(pH 8.5), and 1 M glycine buffer (pH 9.6), respectively. For
the condition of a different ionic strength, filter spacers of
F5, F6, F7, F8, and F9 were charged with approximately
40 nL of 1 M, 2 M, 3 M, 4 M, and 5 M NaCl solution, re-
spectively. To equalize the volume of solution added to
each well, distilled water was added to the wells notcharged with any of F0–F9 using the templates F0− F9ð Þ
complementary to F0–F9 (the well position of Fi is not a
well in Fi and inversely, a nonwell position of Fi is assigned
as a well in Fi; i = 0, 1, 2). Finally, lysozyme solution
(280 mg/mL) was added (approximately 40 nL) to the wells.
The crystallization was performed by leaving the MMV in
the middle of a closed container (10 cm× 10 cm× 10 cm)
with its interior soaked with 500 mL of 2 M ammonium
sulfate at 20°C for one day to one week. Each well was




A saliva sample was collected from one of the authors (with
their consent), by themselves 5 h after brushing and with
no intake of food in this period. This sample-collection was
performed with the permission of the Saitama University
Ethical Committee on Human-related Research. For sam-
ple collection, two small, sterile sponge pieces were kept
bitten in the mouth for 5 min and then dipped in 1 mL of
Dulbecco’s phosphate buffered saline [DPBS (−)] (pH 7.4)
(Wako Pure Chemical Industries, Ltd.). The saliva was
squeezed out of the sponge pieces and was dissolved in
PBS and subjected to centrifugation for 5 min at 1470 g.
The supernatant was discarded; the pellet was dissolved in
200 μL of DPBS (−) buffer and stored in 13% glycerol
at −80°C.
Deflocculation and cell counting
To dissolve the flocs of cells, 1 μL of the oral sample was
treated with 9 μl of DPBS (−) buffer and 200 pg/μL pro-
teinase K. This solution was sonicated for 40 s, incubated
at 55°C for 1 h and at 95°C for 5 min, and then again soni-
cated for 40 s. This deflocculation-treated solution was
subjected to staining with 10000× diluted SYBR gold solu-
tion, and cells were counted using a Neubauer improved
cell counting chamber.
Single-cell DNA extraction
The oral microbes were suspended in bacterial cell lysis
reaction buffer containing 10 mM Tris–HCl (pH 8.0),
0.025% BSA, 0.10% Tween 20 (Wako Pure Chemical
Industries, Ltd.), and 0.75% polyethylene glycol 8000
(PEG8000, Sigma-Aldrich) to obtain a concentration of
300 cells/700 μL and to lyse the cells. Moreover, achro-
mopeptidase [0.004% (w/v), Wako Pure Chemical Indus-
tries, Ltd.] solution was added to this extraction mixture.
The resulting solution was immediately charged into a
shallow well-type MMV (0.14 μL/well capacity) and then
transferred to a full volume-type MMV (0.5 μL/well cap-
acity) by Z-mode transfer and incubated at 37°C for 1 h
and then at 95°C for 10 min.
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PCR mixture containing 200 μM dNTPs (N =G, A, T, or
C), 0.7 μM primer pfM 19 (5′-CAGGGCGCGTAC-3′),
10 mM Tris–HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2,
0.03 U/μL Taq DNA polymerase (Takara), and an add-
itional solution of 0.025% BSA, 0.75% PEG 8000, and 0.1%
Tween 20 were loaded into the MMV treated with bacter-
ial cell lysis reaction buffer. A dodecamer primer, pfM 19,
was used for random PCR. The MMV chip was sealed
tightly with silicone tape and aluminum foil to prevent
evaporation of the reaction mixture during PCR.
To minimize the amplification of undesirable DNAs
such as primer dimers, the PCR program comprising the
two following series was chosen: i) 15 cycles of denatur-
ation at 94°C for 30 s, annealing at 26°C for 60 s, and ex-
tension at 72°C for 60 s and ii) 20 cycles of denaturation
at 94°C for 30 s, annealing at 60°C for 60 s, and exten-
sion at 72°C for 60 s. PCR was performed using an
MMV PCR machine (Lifetech) or a conventional ther-
mocycler (Bio-Rad C1000 Touch).
After PCR, the MMV was stained with SYBR green I
and monitored using a fluoroimager. MMV wells show-
ing high fluorescence (dark pixels) were selected for
scale-up PCR and transferred to a 96-well PCR plate.
For scale-up PCR, a PCR mixture that composed of
200 μM dNTPs (N =G, A, T, or C), 0.7 μM primer pfM
19, 10 mM Tris–HCl (pH 8.3), 50 mM KCl, 1.5 mM
MgCl2, and 0.02 U/μL Taq DNA polymerase (Takara)
was used. Samples were amplified by 15 cycles of de-
naturation at 94°C for 30 s, annealing at 26°C for 60 s,
and extension at 72°C for 60 s.
PCR product analysis
Random PCR products were analyzed using μTGGE,
which can extract sequence-specific information of
double-stranded DNA without sequencing (Figure 4b and
Additional file 12). Each profile was assigned genome-
specific feature points called spiddos [40], and PaSS (pat-
tern similarity score) was calculated (Additional file 12).
The genome distance dG, defined as the value of 1 − PaSS,
was subjected to clustering analysis to construct a phy-
logenetic tree using the neighbor-joining method with
Phylip 3.69 and MEGA 5.1 software.
Additional files
Additional file 1: Table S1. Unit technologies and accessories of the
MMV system.
Additional file 2: Figure S1. Transfer of solution in a square (thin filter)
to MMV wells (S-mode operation). Here, the holes of a thin filter act as
squares. The filling process is explained in the Figure 1c legend.
Additional file 3: Figure S2. Robotic transfer of solution to an MMV
well (P-mode operation). A robot developed for P-mode transfer in MMV
operations. Both MMV-to-MMV and MMV-to-microplate or other transferscan be performed by this machine. This robot (manufactured by Lifetech)
comprises robotic dispenser arms (1), three platforms [one for microplate
(2) and two for MMVs (5, 6)], a tip or syringe stand (3), a container to
discard used tips (4), and a tip-position sensor (7). The whole system is
controlled by a computer (not shown). The tip-position sensor is required
to adjust and control the fine (10 μm or less) 3D positions of tips.
Additional file 4: Figure S3. Generation of MMV replicas. (a) An
example of preparing an original MMV made of two types of wells
(Elements 1 and 2) in a specific pattern. Element 1-containing MMV
(E1-MMV) was prepared using a specific pattern filter, and similarly,
Element 2-containing MMV (E2-MMV) was prepared with a pattern
complementary to that of E1-MMV. These two MMVs were combined by
transferring the contents of E1-MMV to E2-MMV. (b) The contents of
the original MMV were transferred to the vacant acceptor MMV by
centrifugation and then reversed as shown, leaving a small amount of
solution (seed) in each well of replica MMV. These seeds may be DNA or
cells depending on the type of replica formation. (c) Picture of wells
containing tiny droplets. (d) Actual microscopic image of droplet
containing MMV wells.
Additional file 5: Figure S4. Actual checker-pattern experiment for
verification of MMV solution transfer operation (Z-mode). Methylene blue
dye solution is charged into a checker-pattern packing spacer (filled and
empty wells alternatively) on a small area of the donor MMV and
transferred to the acceptor MMV by Z-mode transfer, thus transferring
solution only to corresponding wells without cross-contamination.
Additional file 6: Figure S5. Ejection of MMV contents (O-mode
operation: washing). (a) View of a polycarbonate MMV. (b) Schematic
representation of solution discharge from an MMV chip. An MMV chip
covered with a sheet of filter and tissue paper is centrifuged to eject the
contained solutions and can be repeatedly washed by the same process.
Additional file 7: Figure S6. Division of solutions in MMV (X-mode
operation). A filter patterned with two small holes per well was attached
to an empty acceptor MMV and was tightly bound to a filled (donor)
MMV. These sets of MMVs were subjected to centrifugation directed
parallel to the MMV surface. On centrifugation, the liquids were divided
into two portions in the facing donor and acceptor MMV wells.
Additional file 8: Figure S7. Magnetic bead recovery from solutions
(M-mode operation). Magnetic beads bound to the desired molecules
can be recovered by the following steps. Mixing of beads-containing
solution can be performed by sealing the solution in MMV with silicone
tape and the alternative attractive force of magnets. The recovered
magnetic beads bind the desired molecule ‘A’ on their surface via the
‘anti-A’ molecule directly bound to the bead.
Additional file 9: Figure S8. Magnetizable bead-assisted division of
liquid (M-mode operation). Using packing with holes smaller than the
bead diameter, the solution in the 70% volume of MMV can be retained
during centrifugation [step b) to c)].
Additional file 10: Figure S9. Pipette-dependent transfer of solution in
an MMV well (P-mode operation). (a) Image of a pipette, tip, and MMV
chip. (b) Close-up view of manual pipette operation along MMV wells.
Additional file 11: Figure S10. Generation of diverse conditions.
N-times of 2 state (2N) method. Each well of an MMV can be uniquely
assigned by a binary number composed of N-bits (here, N = 4). Here, “0”
or “1” at each position of a binary number corresponds to the absence
or presence, respectively, of a specific component input using the
corresponding plate. Thus, “0000” means the absence and “1111” the
presence of all four components. Similarly, “0101” implies the presence of
only the second and fourth components.
Additional file 12: 2N method, genome profiling, μTGGE, sequencing
analysis, and peptide aptamer selection: panning on microarray MMV
(POMM) methods are described in detail.
Additional file 13: Figure S11. Phase-diagram-like presentation of
lysozyme crystals. (a) Different conditions composed of pH (2.9–9.6) and
ionic strength (NaCl: 0–1.5 M) generated different types of lysozyme
crystals. Each shape of crystal in MMV wells is depicted in different colors.
Four main types of crystals (large and small tetragonal crystals and
microcrystalline and needle-like crystals) were observed. (b) Microscopic
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crystallization reproducibility experiment (at 50 μL scale) performed under
one of the conditions generated in the MMV chip, i.e., 0.6 M NaCl and
pH 8.6. The scale bar is 100 μm.
Additional file 14: Figure S12. Original genome profiles obtained from
random PCR-successful microbial samples appearing in the MMV-PCR
experiment. Samples that have been successfully processed up to
clustering analysis (Figure 4d in text) are shown. Sample feature points
(pre-spiddos) and internal reference points are indicated by red and
yellow dots, respectively.
Additional file 15: Table S2. BLASTN-aided tentative assignment of
species for each DNA band in the NNMA experiment.
Additional file 16: Table S3. Basic data obtained for three trials of the
NNMA experiments.
Additional file 17: Figure S13. Well-to-well transfer by nanoliter
dispenser robot. Transfer of 0.1 μL volume of solution from upper donor
wells (A, B, and C) to lower acceptor wells (A′, B′, and C′) by robotic
transfer in the same MMV. In this experiment, around 5% solution
(0.005 μL) is left after transfer as shown in the crescent shape (upper row)
due to the difficulty of withdrawing all the solution.
Additional file 18: Figure S14. Micro-high-throughput screening
(μ-HTS) of Aβ-binding peptides by panning on microarray MMV (POMM).
A DNA library of candidate sequences was transferred to the MMV. Each
candidate sequence contained the T7 promoter region and was tagged
with 3× FLAG. MMV PCR was performed, and MMV was replicated. The
replica MMV was stored (at −20°C) for future replication and screening
experiments. For subsequent steps, the original MMV was used. DNA
sequences were in vitro transcribed and translated (IVT) (see Additional
file 12). Selectively Aβ 42-binding peptides were extracted using
streptavidin magnetic beads and biotin-conjugated Aβ 42. MMV was
thoroughly washed to eliminate everything except binding peptides.
FITC-labeled anti-FLAG antibody solution was added, MMV was washed,
and peptides were released by proteinase K treatment. MMV was
visualized in the detection unit (CCD camera or TRF unit or laser scanner
with FITC filter). In addition, MMV wells stained with FITC indicated the
presence of Aβ-42 binding peptides, resulting in fluorescence, whereas in
the absence of Aβ-binding peptide, FITC-labeled anti-FLAG antibody did
not bind and was washed out in the initial steps, thus resulting in no
fluorescence.
Additional file 19: Figure S15. Deflocculation of an oral microbiome
sample. (a) Microscopic view of SYBR gold-stained negative (PBS buffer
only), positive (oral microbiome sample without treatment), heat (positive
sample with heat treatment only), and proteinase K (positive sample with
proteinase K treatment only) samples. (b) Phase-contrast microscopic
images of an oral microbiome sample treated with proteinase K only and
with both proteinase K and sonication (for 1 min). The scale bar is 50 μm
for both (a) and (b). The ratio of single to flocculated cells was
approximately 100:1.
Additional file 20: Figure S16. A trial semiconductor-based apparatus
for the evaluation of solution conductivity in MMV wells. The conductivity
of the solution in a particular well can be selectively monitored by
laser-light illumination through light-transparent semiconductor ITO and
photoconductive polymer membrane. The figure shows the redox
reaction occurring on the surface of the photoconductive polymer
membrane.
Additional file 21: Table S4. Tentative cost comparison of the reagents
required in MMV and a 96-well microplate (for 1000 reactions). (a) Cost
comparison for a multistep function-based screening experiment. (b)
Cost comparison for the experiment of apoptosis detection in HeLa cells.
The prices were taken from those in 2012 in Japan for both tables
(a) and (b).
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